RIPK3 and neoplasm: Some other studies have reported that treatment with chemotherapeutic drugs induces the formation of the RIPK1/RIPK3/CASPASE-8 ripoptosome complex that triggers necroptotic cell death and that knockdown of RIPK3 can inhibit this killing of tumour cells [2–6].